HK Stock MarketDetailed Quotes
01244 3D MEDICINES
Watchlist
23.450
-2.250-8.75%
Market Closed 09/21 16:08 CST
26.250High23.400Low318.50KVolume
25.800Open25.700Pre Close7.72MTurnover0.12%Turnover RatioLossP/E (TTM)6.05BMarket Cap131.50052wk HighLossP/E (Static)258.21MShares23.40052wk Low6.37P/B6.05BFloat Cap131.500Historical High--Dividend TTM258.21MShs Float23.400Historical Low--Dividend LFY11.09%Amplitude--Div YieldTTM24.247Avg Price500Lot Size--Div Yield LFY
3D MEDICINES Key Stats
All
YOY
| (FY)2022/12/31 | (FY)2021/12/31 | (FY)2020/12/31 | (FY)2019/12/31 | |
|---|---|---|---|---|
| Cash flow from operating activities | ||||
| Earning before tax | 28.03%-1.05B | -130.07%-1.46B | -98.29%-635.38M | ---320.43M |
| Profit adjustment | ||||
| Interest (income) - adjustment | -31.04%-7.21M | -241.74%-5.5M | -1,025.87%-1.61M | ---143K |
| Investment loss (gain) | -350.24%-1.91M | -171.79%-424K | -609.09%-156K | ---22K |
| Impairment and provisions: | 803.85%1.18M | --130K | --0 | --0 |
| -Other impairments and provisions | 803.85%1.18M | --130K | ---- | ---- |
| Revaluation surplus: | -31.17%657M | 199.02%954.56M | 24,102.58%319.23M | --1.32M |
| -Other fair value changes | -31.17%657M | 199.02%954.56M | 24,102.58%319.23M | --1.32M |
| Asset sale loss (gain): | --0 | 47,850.00%959K | -33.33%2K | --3K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 47,850.00%959K | -33.33%2K | --3K |
| Depreciation and amortization: | 71.55%21.6M | 273.51%12.59M | 44.49%3.37M | --2.33M |
| -Depreciation | 71.90%21.5M | 271.02%12.51M | 44.49%3.37M | --2.33M |
| -Amortization of intangible assets | 20.24%101K | --84K | ---- | ---- |
| Financial expense | 103.73%3.11M | -81.04%1.53M | -47.01%8.06M | --15.21M |
| Exchange Loss (gain) | -1,042.42%-34.86M | -37.59%3.7M | 908.59%5.93M | ---733K |
| Special items | -9.80%141.69M | 37,659.62%157.08M | -98.40%416K | --26.07M |
| Operating profit before the change of operating capital | 19.51%-271.43M | -12.35%-337.2M | -8.59%-300.14M | ---276.4M |
| Change of operating capital | ||||
| Inventory (increase) decrease | -9,000.00%-1.18M | ---13K | ---- | ---- |
| Accounts receivable (increase)decrease | 79.83%-13.06M | -21,705.39%-64.76M | -371.43%-297K | ---63K |
| Accounts payable increase (decrease) | 184.65%96.52M | 870.44%33.91M | -109.61%-4.4M | --45.79M |
| prepayments (increase)decrease | -2,478.18%-101.04M | -122.73%-3.92M | 1,775.70%17.24M | ---1.03M |
| Cash from business operations | 21.99%-290.2M | -29.34%-371.99M | -24.12%-287.6M | ---231.71M |
| Special items of business | 324.19%11.42M | -154.95%-5.09M | 196.57%9.27M | ---9.6M |
| Net cash from operations | 26.07%-278.78M | -35.48%-377.08M | -15.34%-278.33M | ---241.3M |
| Cash flow from investment activities | ||||
| Interest received - investment | 28.93%7.07M | 240.50%5.48M | 1,025.87%1.61M | --143K |
| Loan receivable (increase) decrease | 77.34%-997K | ---4.4M | --0 | ---- |
| Decrease in deposits (increase) | --0 | 200.00%6M | ---6M | ---- |
| Sale of fixed assets | ---- | ---- | --4K | ---- |
| Purchase of fixed assets | -23.04%-53.98M | -293.58%-43.87M | -21,336.54%-11.15M | ---52K |
| Purchase of intangible assets | ---- | ---12.51M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---11.12M | ---- |
| Recovery of cash from investments | 427.08%265.77M | 717.11%50.42M | -69.18%6.17M | --20.02M |
| Cash on investment | -359.97%-459.97M | ---100M | ---- | ---6M |
| Net cash from investment operations | -144.87%-242.11M | -382.77%-98.87M | -245.11%-20.48M | --14.11M |
| Net cash before financing | -9.44%-520.89M | -59.28%-475.95M | -31.52%-298.81M | ---227.19M |
| Cash flow from financing activities | ||||
| New borrowing | --149.04M | ---- | -98.45%3.52M | --227.95M |
| Refund | -443.41%-19.14M | 97.43%-3.52M | 58.97%-136.9M | ---333.65M |
| Issuing shares | -80.58%313.52M | 105.97%1.61B | 98.27%783.82M | --395.34M |
| Interest paid - financing | -25.00%-1.91M | 91.29%-1.53M | -144.36%-17.53M | ---7.18M |
| Absorb investment income | ---- | --332.78M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 97.92%-22.59M | -3,423.90%-1.09B | ---30.84M | ---- |
| Other items of the financing business | 30.59%-10.51M | -384.27%-15.15M | 424.68%5.33M | ---1.64M |
| Net cash from financing operations | -51.38%408.41M | 38.31%840.08M | 116.29%607.39M | --280.82M |
| Effect of rate | 954.07%34.91M | 36.86%-4.09M | -794.53%-6.47M | --932K |
| Net Cash | -130.89%-112.47M | 18.00%364.13M | 475.38%308.58M | --53.63M |
| Begining period cash | 86.91%774.31M | 269.36%414.26M | 94.74%112.16M | --57.59M |
| Cash at the end | -10.02%696.74M | 86.91%774.31M | 269.36%414.26M | --112.16M |
| Cash balance analysis | ||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--